INTRODUCTION
The importance of the functioning of the seven-transmembrane G-protein-coupled receptors (GPCRs) was recently underscored by the revelation that 5 % of all Caenorhabditis elegans genes code for this class of proteins [1] . This prominence is indicative of the widespread utility and cruciality of these proteins. According to current understanding, GPCRs require G-proteins to convey messages to intracellular targets. Two classes of Gproteins have been identified that fulfil this function. One class consists of the highly investigated classical heterotrimeric Gproteins [2, 3] , such as G q/"" that links receptors to the intracellular enzyme phospholipase C (PLC), which cleaves phosphoinositides (PIs). The second class, which includes tissue transglutaminase (tTG) [4] , has received relatively little attention. Thus basic critical questions remain unresolved, such as how GPCRs interact with tTG and how this interaction affects signalling activity.
tTG is a unique multifunctional protein that exhibits three distinct enzymic activities ; a calcium-dependent transamidating activity that crosslinks proteins or incorporates polyamines into substrates [5, 6] , GTPase activity [7] [8] [9] and ATPase activity, with separate binding sites for Mg-ATP and Mg-GTP [9] . Substantial evidence indicates that each of these activities is distinct ; however, there are interactions. For example, GTP inhibits the transamidating activity of tTG activity [7] and Mg-ATP inhibits the GTPase activity but has no effect on transamidation [9] . In addition, the transamidating activity of tTG apparently does not effect the signal-transducing function of tTG. A Cys Ala mutation within the active site for transamidation eliminated this activity [10] , but did not alter the ability of tTG to functionally couple to the α "B adrenoreceptors [11] . The GTP-binding and GTPase activities were found to be critical properties, allowing tTG to function as a signalling intermediary coupling cell-surface receptors to intracellular effectors [4, [11] [12] [13] . Based on this, tTG has been referred to as occupancy of the receptor. In addition, the effects of tTG on signalling are bimodal. At low expression levels, tTG enhanced α "B adrenoreceptor-stimulated PI hydrolysis, whereas at higher expression levels tTG attenuated significantly this response. These findings are the first to demonstrate that a protein can both facilitate and attenuate receptor-stimulated PI hydrolysis.
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Gα h [4] , by analogy to the nomenclature of heterotrimeric Gproteins, although tTG does not bind βγ units as do classical heterotrimeric G-proteins [13] . In reconstitution studies in COS1 cells, tTG was capable of coupling the α "B and α "D adrenoreceptors (but not α "A adrenoreceptors) to PLCδ, and thus function as a signal-transducing G-protein [4, [11] [12] [13] . There is also evidence that tTG functionally couples the oxytocin receptor to PLCδ in myometrium [14] . However, the α1 adrenoreceptor and oxytocin receptor also effectively couple to the classical heterotrimeric G-protein, G q/"" [11, 15, 16] . Further, co-transfection of the α "B adrenoreceptor and G q/"" into COS1 cells resulted in greater (k)epinephrine (adrenaline)-stimulated PI hydrolysis than in cells co-transfected with the receptor and tTG [11] . These findings indicate clearly that further investigations are required to clarify the putative role of tTG in signal transduction.
Although these previous studies indicate clearly that tTG can mediate receptor-coupled signal-transduction activity, tTG differs substantially from the ' classical ' α-subunit of heterotrimeric G-proteins. tTG does not have GTP-binding motifs common to heterotrimeric G-protein α-subunits [2, 13] . tTG does not activate PLCβ, which is the PLC isozyme activated by the heterotrimeric G-protein α-subunits [17, 18] , but rather has an eight amino acid stretch in the C-terminal region that is essential for binding and activating PLCδ [12, 19] . In addition, no ' βγ-like ' subunits are apparently required for tTG to function in its signal-transducing capacity, although a 50-kDa protein was found to co-purify with tTG and to decrease GTP binding and GTPase activity [20] . However the 50-kDa protein does not modulate receptor-tTG interactions [13, 20] . Thus it is clear that tTG is not a member of the classical heterotrimeric G-protein family.
Based on these previous findings, this study was designed to examine the novel role of tTG in mediating the activation of PLC in response to stimulation of the α "B adrenoreceptor in a neuronal-like cell line. All previous investigations of the role of tTG in GPCR signalling have been carried out in itro or in nonneuronal cells. Human neuroblastoma SH-SY5Y cells do not contain α " adrenoreceptors [21] , and the levels of tTG expressed in the cells can be regulated by treating cells with drugs such as retinoic acid [6] and azacytidine [22] . Therefore stable transfection of these cells with the α "B adrenoreceptor yielded a suitable neuronal-like cell model for evaluating the signal-transduction role of tTG through just the α "B adrenoreceptor subtype. The results of these studies demonstrate that expression of the α "B adrenoreceptor selectively recruits both tTG and PLCδ to the membrane, but not G q/"" or PLCβ. Further, activation of the α "B adrenoreceptor enhanced the translocation of tTG to the membrane. In addition, the effects of tTG on signalling through the α "B adrenoreceptor are bimodal. At low expression levels, tTG enhanced α "B adrenoreceptor-stimulated PI hydrolysis, whereas at higher expression levels, tTG significantly attenuated signalling through the α "B adrenoreceptor. These findings are the first to demonstrate that a protein can both facilitate and attenuate GPCR-stimulated PI hydrolysis. Further evidence is provided that even at optimal facilitatory levels, the direct contribution of tTG to α "B adrenoreceptor-stimulated PI hydrolysis is relatively small compared with G q/"" , and therefore the primary role of tTG in GPCR signalling is likely to be more modulatory rather than in the capacity of a classical signal-transducing G-protein.
These and other findings clearly indicate that tTG does not function in the capacity of a classical heterotrimeric G-protein, but rather plays a novel role in modulating α "B adrenoreceptorcoupled signalling activity.
EXPERIMENTAL Materials
5-Azacytidine, BSA, carbachol, GTP, GTPγS, genistein, guinea pig liver tTG, -phenylephrine, phentolamine, prazosin and retinoic acid were purchased from Sigma (St. Louis, MO, U.S.A.). 2-Fluoropalmitic acid was from Alexis (San Diego, CA, U.S.A.) ; PMSF, SDS and FuGENE4 6 were purchased from Roche (Indianapolis, IN, U.S.A.). The enhanced chemiluminescence (ECL) reagents and -3-phosphatidyl [2-$H]inositol (18 Ci\mmol) were purchased from Amersham (Boston, MA, U.S.A.). [2-$H(n)]myo-inositol (20 Ci\mmol) was from American Radiolabeled Chemicals (St. Louis, MO, U.S.A.). [7-methoxy-$H]Prazosin (77.2Ci\mmol) was from New England Nuclear (Boston, MA, U.S.A.). BCA protein-assay reagents were purchased from Pierce (Rockford, IL, U.S.A.). Nonidet P-40 and rabbit non-immune IgG were purchased from Calbiochem (La Jolla, CA, U.S.A.). RPMI 1640 was purchased from Cellgro (Hermdon, VA, U.S.A.) ; penicillin\streptomycin and horse serum, geneticin (G418) and lipofectamine were from Gibco BRL (Gaithersburg, MD, U.S.A.). Fetal bovine serum was purchased from Atlanta Biologicals (Norcross, GA, U.S.A.). Fetal Clone II was purchased from Hyclone (Logan, UT, U.S.A.). The tTG monoclonal antibody 4C1 was produced by the Hybridoma Core Facility at University of Alabama at Birmingham [23] . The tTG monoclonal antibodies TG100 and CUB7402 were from NeoMarkers (Union City, CA, U.S.A.). The tTG polyclonal antibody was purchased from UBI (Lake Placid, NY, U.S.A.). The PLCδ1 monoclonal antibody was from Transduction Laboratories (Lexington, KY, U.S.A.), and PLCβ1 polyclonal antibody was from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Horseradish peroxidase-conjugated goat anti-mouse IgG was purchased from Bio-Rad (Hercules, CA, U.S.A.). The expression vector pcDNA3.1j was from Invitrogen (Carlsbad, CA, U.S.A.), and the remaining molecular-biology reagents were purchased from Promega (Madison, WI, U.S.A.).
Vectors and DNA constructs
The cDNA for α "B adrenoreceptor in the vector PMT2h [11, 24, 25] was provided kindly by Dr. M. J. Im, and the cDNA for human tTG in the vector pSG5 [26, 27] was a generous gift from Dr. P. Davies. The cDNA for the α "B adrenoreceptor was cut out of PMT2h with EcoRI\NotI and ligated into the same sites of pcDNA3.1j (α "B \pcDNA). The cDNA for human tTG was cut out of pSG5 with EcoRI and inserted into the same site of pcDNA3.1j (TG\pcDNA).
Cell culture and transfection of cells
Human neuroblastoma SH-SY5Y cells were maintained on Corning dishes in continuous culture media (RPMI 1640 medium supplemented with 20 mM glutamine, 10 units\ml penicillin, 100 µg\ml streptomycin, 5 % Fetal Clone II serum and 10 % horse serum). Stably transfected cells were maintained with transfection-maintenance medium that contained 100 µg\ml G418 (geneticin) and 5 % fetal bovine serum instead of Fetal Clone II ; other components were the same as continuous culture media.
For stable transfection, SH-SY5Y cells were replated 1 day before electroporation. The cells were removed from the dish with RPMI 1640 medium containing 0.05 % of trypsin and 0.053 mM EDTA, diluted with continuous culture medium and centrifuged for 5 min at 250 g. Cells (3i10') resuspended in 1 ml of Hepes buffer (0.14 M NaCl, 25 mM Hepes, 0.075 mM NaHPO % , pH adjusted to 7.05 with 10 M NaOH), were mixed with 10 µg of linearized α "B \pcDNA and kept on ice for 10 min. Electroporation was carried out with a Bio-Rad Pulse II set at 0.25 kV and 960 µF as described previously [28] . After electroporation cells were incubated on ice for 10 min and then mixed with 10 ml of continuous culture medium and plated on to a 100-mm Corning dish. After 48 h, the cells were collected and reseeded on to 10 100-mm Corning dishes at very low densities ($ 1000 cells\dish) in transfection-maintenance medium. Cells were maintained in transfection-maintenance medium for $ 1 month until individual cells, which contained the plasmid and thus were resistant to geneticin, formed small colonies. Individual colonies were collected and transferred into each well of a 24-well Corning plate. The cells were grown and the cultures expanded prior to screening for positive clones by prazosin binding and the PI hydrolysis assay (see below).
For transient transfection of the α "B adrenoreceptor or tTG, the constructs were introduced into the cells either with lipofectamine or FuGENE4 6 using the manufacturer's protocol. To induce tTG expression with retinoic acid or azacytidine, the cells were incubated with the indicated concentrations for 3-6 days. Treatment with 10 µM retinoic acid for 3 days resulted in a small decrease in viability as determined by lactate dehyrogenase release [6] . In control cells there was 7.4p0.5 % lactate dehyrogenase released, while in the retinoic acid-treated cells the values were 10.0p0.5 % (n l 6 separate determinations). All experiments were carried out on subconfluent cultures.
Ligand binding
To screen for clones expressing the α "B adrenoreceptor, a previously described binding assay was used [21] with some modifications. Transfected cells were harvested by trypsin digestion and rinsed twice with a Krebs buffer (122 mM NaCl,
.6 mM NaHCO $ , 11 mM glucose and 30 mM Hepes, pH 7.35). The cells were resuspended in Krebs buffer and aliquoted [(1-2)i10' cells\aliquot]. The total binding-reaction volume was 500 µl per assay including 0.4 mg\ml BSA and [$H]prazosin (0.12 µCi\ml). To measure non-specific binding, 1.6 µM phentolamine, another α " adrenoreceptor antagonist, was also included. The reactions were incubated at 4 mC for 1 h with continuous shaking, and stopped by filtering on to GF\B filters and rinsing with 5 ml of washing buffer (140 mM NaCl, 5 mM MgCl # , 1 mM EGTA, 50 mM Tris\HCl, pH 7.2). The filters were then subjected to scintillation counting. To determine the binding constant of the expressed α "B adrenoreceptor, the cells were incubated with [$H]prazosin in the presence of increasing concentrations of unlabelled prazosin and the binding constant (K d ) was determined by fitting data with a linear-regression program as described by Lin and Riggs [29] . All values were obtained from at least three independent experiments measured in triplicate.
PI hydrolysis assay
Measurements of PI hydrolysis were carried out as described previously [30] . Cells were pre-labelled with [$H]myo-inositol (75 µCi\100 mm plate) for 48 h. The labelled cells were harvested, rinsed twice with Krebs buffer and resuspended in Krebs buffer containing 10 mM LiCl. Aliquots (1i10' cells) were preincubated at 37 mC for 5 min, 50 µM phenylephrine, or other drugs as indicated, was added and the incubation continued for 1 h at 37 mC. The reactions were terminated by adding 1.7 ml of methanol\chloroform\HCl (2 : 1 : 0.01, by vol.). Samples were fractionated and [$H]inositol monophosphate measured as described previously [30] . All values were obtained from triplicate measurements from at least three independent experiments, and data are expressed as meanspS.E.M.
Plasma-membrane preparation
Cells were suspended and sonicated in lysis buffer (0.32 M sucrose, 100 mM NaCl, 2 mM MgCl # , 1 mM EDTA, 1 mM EGTA, 0.5 mM dithiothreitol, 0.1 mM PMSF, 10 µg\ml each of aprotinin, leupeptin and pepstatin, and 50 mM Tris\HCl, pH 7.3), and the lysates were spun at 700 g for 10 min. The postnuclear supernatant was spun at 100 000 g for 1 h to separate the membrane and cytosol fractions, and the resulting membrane pellet was washed three times with lysis buffer before use in the assays. In some cases, 2 mM GTP, 50 µM phenylephrine or 1 µM prazosin was also included during the preparation.
Membrane PI hydrolysis
Membranes were resuspended in membrane-assay buffer containing 5 mM Trizma 2 -maleate, pH 7.0, 8 mM LiCl, 5 mM MgCl # , 3.0 mM EGTA and 1.36 mM CaCl # (these concentrations of EGTA and CaCl # yielded a free calcium concentration of 300 nM). Aliquots (75 µg of protein\100 µl of total reaction volume) were incubated in the presence of [$H]PI (0.005 µCi\ 100 µM) for 1 h at 37 mC either with or without 25 µM GTPγS, 50 µM phenylephrine and different concentrations of tTG as indicated. The reaction was terminated by adding chloroform\ methanol (1 : 2, v\v), and the labelled products were extracted as described previously [31] .
PI hydrolysis in streptolysin-O-permeabilized cells
To examine the rate in situ of PI hydrolysis after selectively blocking either G q/"" or tTG function, cells were permeabilized with streptolysin-O prior to incubation with antibodies against these proteins using a modification of a protocol described previously [32] . Cells prelabelled with [$H]inositol for 48 h were harvested, rinsed twice with Ca# + -free Krebs buffer and resuspended in Ca# + -free Krebs buffer containing 1 mM dithiothreitol. The cell suspension was kept on ice for 10 min. Streptolysin-O (final concentration 100 haemolytic units\ml) was added to the cell suspension, and samples were incubated for 20 min at 4 mC. The cells were spun, resuspended in incubation buffer (calcium-free Krebs buffer supplemented with 300 nM CaCl # , 1 mM dithiothreitol, 2 mM GTP and 5 mM magnesium acetate), aliquoted [(1-2)i10' cells\500 µl] and pre-incubated with selected antibodies or non-immune-IgG (all at 10 µg\ml) at 30 mC for 1 h. Phenylephrine was then added to the cell suspension at a final concentration of 50 µM, and the incubation was continued for another 1 h at 30 mC. PI hydrolysis was measured as described above.
Immunoblotting
To evaluate levels of tTG, G q/"" , PLCδ1 or PLCβ1, cell extracts or membranes were prepared and quantitatively immunoblotted as described previously [6] . The blots were probed with the anti-tTG monoclonal antibodies 4C1 (1-2 µg\ml) or TG100 (0.1 µg\ml), the anti-Gq "" polyclonal antibody Q253 (0.05 µg\ ml), the anti-PLCδ1 monoclonal antibody (0.4 µg\ml) or the anti-PLCβ1 polyclonal antibody (0.4 µg\ml) in 5 % milk\borate saline buffer (100 mM boric acid, 20 mM sodium borate, 80 mM NaCl and 0.05 % Nonidet P-40). The immunoblots were developed with ECL, and analysed using a Bio-Rad GS-670 Imaging Densitometer. To quantitatively measure the amounts of tTG in the membrane fraction, 3 ng of guinea pig liver tTG was run on each gel as an internal standard. Samples (20 µg\lane) and the standard were electrophoresed, immunoblotted and the blots developed with ECL. The blots were quantified by densitometry and the values normalized to the guinea pig liver tTG standard. The normalized data from both whole homogenate and membrane were then compared.
Statistical analysis
Statistical significance was determined using analysis of variance, with a Tukey-Kramer multiple-comparisons test where appropriate. The values were considered significantly different if the P value was 0.05.
RESULTS

Selection of α 1B adrenoreceptor-expressing clone
In initial studies, over 20 geneticin-resistant clones were screened for prazosin binding, and seven of these clones showed binding activity. The seven clones that showed prazosin-binding activity were assayed to determine if the expressed α "B adrenoreceptors showed specific agonist stimulation of PI hydrolysis. Out of the seven clones, three showed phenylephrine-stimulated PI hydrolysis. The clone that showed the highest level of α "B adrenoreceptor expression and greatest PI hydrolysis in response to phenylephrine was chosen for full characterization and subsequent studies.
Characterization of α 1B adrenoreceptor expression and function
α "B Adrenoreceptor density was measured in untransfected wildtype human neuroblastoma SH-SY5Y cells and in cells either transiently or stably transfected with the α "B adrenoreceptor. As reported previously, no α " adrenoreceptors were detected in human neuroblastoma SH-SY5Y cells [21] . Stable transfection resulted in significantly higher levels of α "B adrenoreceptor expression (2048p50 fmol\mg) than transient transfection (1090p30 fmol\mg) ; therefore, the majority of experiments were carried out with stably transfected cells. The binding constant (K d ) of the α "B adrenoreceptor for the selective antagonist prazosin in stably transfected cells was 0.12p0.03 nM, which is similar to previously reported values [33] .
To determine whether the α "B adrenoreceptor in the stably transfected cells was functional, receptor-coupled activation of PI hydrolysis was measured using phenylephrine, a selective α " adrenoreceptor agonist. Phenylephrine (50 µM) stimulated PI hydrolysis in transfected cells, but not in wild-type cells ( Figure  1) , and as expected this stimulation was potently inhibited by prazosin (IC &! l 2.5p0.2 nM ; results not shown). SH-SY5Y cells express cholinergic muscarinic M3 receptors coupled to PLCβ by G q/"" [34, 35] . Stimulation with the cholinergic agonist carbachol induced equivalent activation of PI hydrolysis in wildtype and α "B adrenoreceptor-transfected cells (Figure 1 ). Atropine (10 nM) completely blocked the carbachol-induced increase in PI hydrolysis, but as expected had no effect on the phenylephrine-stimulated increases in PI hydrolysis (results not shown).
The α 1B adrenoreceptor selectively recruits tTG to the membrane
To investigate the interactions of the α "B adrenoreceptor with tTG and G q/"" , the localization of these G-proteins was examined in wild-type and α "B adrenoreceptor-transfected cells. Immunoblot analysis revealed that, in wild-type cells, relatively little tTG was membrane-bound, but expression of the α "B adrenoreceptor resulted in a significant increase in the amount of tTG in the membrane fraction (Figure 2 ). The α "B adrenoreceptor-induced membrane translocation of tTG was evident in both undifferentiated cells and cells differentiated with retinoic acid (1 µM for 3 days) to increase tTG levels ( Figure 2) . The amount of membrane-bound tTG was increased further when α "B adrenoreceptor-expressing cells were treated with phenylephrine before and during the membrane preparation, and was slightly decreased when the antagonist prazosin was included (Figure 3) . G q/"" is predominantly membrane-bound, and equivalent amounts of G q/"" were present in the membrane fractions from wild-type and α "B adrenoreceptor-transfected SH-SY5Y cells, and unaffected by the presence of phenylephrine or prazosin (Figure 3 ). Transient transfection of tTG into wild-type SH-SY5Y cells or cells stably transfected with the α "B adrenoreceptor yielded similar results : tTG was recruited to the membrane by the α "B adrenoreceptor ( Figures 4A and 4B ). Further, PLCδ was also recruited to the membrane by the α "B adrenoreceptor ( Figures 4C and 4D) , presumably due to its interaction with tTG [12, 13] . The presence of the α "B adrenoreceptor had no effect on the distribution of PLCβ between the membrane and cytosol (results not shown). Increasing the levels of tTG either by treating with retinoic acid or azacytidine had no effect on the expression levels of
tTG bimodally modulates phenylephrine-stimulated PI hydrolysis
To test if receptor-coupled stimulation of PI hydrolysis is modulated by the level of tTG, three methods were used to increase tTG levels, followed by measurement of phenylephrineinduced PI hydrolysis. Because retinoic acid increases tTG expression in SH-SY5Y cells [6] , treatment with retinoic acid was used to increase tTG expression in cells transfected with the α "B adrenoreceptor. Cells were treated with 0.1-10 µM retinoic acid for 3 days, and then tTG levels and phenylephrine-stimulated PI hydrolysis were measured. Retinoic acid induced a concentrationdependent increase in tTG levels, with 10 µM retinoic acid causing a maximal increase that was 650 % of control levels ( Figure 5A ). Associated with retinoic acid-induced increases in tTG levels, there was a biphasic change in phenylephrinestimulated PI hydrolysis. PI hydrolysis in response to phenylephrine increased with increasing levels of tTG up to a retinoic acid concentration of 1 µM. However, further increases in the tTG levels attenuated the increase in phenylephrine-stimulated PI ( Figure 5A ).
Azacytidine has been shown to increase tTG expression by demethylating the promoter region of the tTG gene [22] . Treatment of the cells with 5 µM of azacytidine for 3 days increased tTG levels and significantly increased phenylephrine-stimulated PI hydrolysis ( Figure 5B ). However, 6 days of treatment of azacytidine, which resulted in a further increase in tTG, slightly decreased phenylephrine-stimulated PI hydrolysis compared with 3 days of treatment ( Figure 5B ).
Because retinoic acid and azacytidine regulate the expression of other proteins besides tTG and thus could indirectly alter PI hydrolysis, α "B adrenoreceptor-expressing cells were transiently transfected with human tTG, and PI hydrolysis in response to phenylephrine was examined. In these experiments tTG\pcDNA was transfected into the cells and phenylephrine-stimulated PI hydrolysis was measured before (time 0) and at 12, 24 and 48 h after transfection. As found with the other models, a moderate increase in tTG expression resulted in an increase in phenylephrine-stimulated PI hydrolysis, but higher expression levels of tTG attenuated the response ( Figure 5C ). Sham transfection of the cells with vector alone had no effect on phenylephrine-stimulated PI hydrolysis (results not shown). Thus the results from three different experimental protocols indicated that tTG bimodally regulates signalling through the α "B adrenoreceptor. To demonstrate further that high levels of tTG expression inhibit phenylephrine-stimulated PI hydrolysis, SH-SY5Y cells that were stably transfected with tTG (TG\pcDNA) or vector only [pcDNA3.1(j)], were transiently transfected with the α "B adrenoreceptor and 48 h later phenylephrine-stimulated PI hydrolysis was measured. The cells stably transfected with tTG expressed high levels of the protein, $ 6-8 fold over the levels of tTG in cells stably transfected with vector only [36] . In these experiments phenylephrine-stimulated PI hydrolysis in the cells overexpressing tTG was 79p3 % less than in the cells with vector alone. These findings demonstrate clearly that high levels of tTG expression can significantly attenuate phenylephrinestimulated PI hydrolysis.
Figure 3 Phenylephrine selectively increases the recruitment of tTG to the membrane
tTG and G q/11 immunoblots of membranes from undifferentiated cells stably transfected with the α lB adrenoreceptor in the absence (k) or presence of phenylephrine (jPE) or prazosin (jPR). Prior to membrane preparation the undifferentiated cells were harvested with Krebs buffer and incubated at 37 mC for 60 min in presence or absence of phenylephrine (50 µM) and/or prazosin (1 µM). These data demonstrate that the agonist binding of the α lB adrenoreceptor increases the presence of tTG at the plasma membrane, but that antagonist prohibits this process. In contrast, both phenylephrine and prazosin do not alter the association of G q/11 on the membrane. Immunoblots are representative of data from three independent experiments.
Figure 4 The α 1B adrenoreceptor recruits both tTG and PLCδ to the plasma membrane
Wild-type untransfected SH-SY5Y cells (SH) and cells stably transfected with the α lB adrenoreceptor (α lB ) were transiently transfected with human tTG. Homogenates (A and C) and membranes (B and D) were immunoblotted for tTG (A and B) or PLCδ (C and D). These results demonstrate that, in cells expressing the α lB adrenoreceptor, there is significantly more tTG and PLCδ at the membrane than in wild-type cells. Immunoblots are representative of data from three independent experiments.
In contrast to these findings, increasing tTG levels by treatment with retinoic acid or azacytidine had no effect on carbacholstimulated PI hydrolysis ( Figure 5D ).
tTG modulates PI hydrolysis in membranes
To examine further the role of tTG in regulating phenylephrinestimulated PI hydrolysis, membrane preparations from cells
Figure 5 tTG bimodally modulates PI hydrolysis in response to stimulation of the α lB adrenoreceptor
(A) α 1B Adrenoreceptor-expressing cells were differentiated by treating with the indicated concentrations of retinoic acid for 3 days, and then PI hydrolysis in response to phenylephrine (50 µM; >), and the levels of tTG ($) in the corresponding groups, were measured quantitatively. Up to a concentration of 1 µM retinoic acid, phenylephrine-stimulated PI hydrolysis increased as tTG levels increased. However, at higher concentrations of retinoic acid and further increases in tTG levels, agonist-stimulated PI hydrolysis was attenuated. A representative immunoblot showing the tTG levels at the retinoic acid concentrations indicated is shown above the graph in (A). (B) α 1B Adrenoreceptor-expressing cells were treated with (j) or without (k) 5 µM azacytidine (AZ) for 3 or 6 days, and then PI hydrolysis in response to phenylephrine (50 µM), and the levels of tTG in the corresponding groups, were measured quantitatively. There was a significant increase in α 1B adrenoreceptor-stimulated PI hydrolysis corresponding to increased tTG levels at day 3, but the higher expression of tTG that occurred after 6 days of treatment with azacytidine resulted in a slight decrease in phenylephrine-stimulated PI hydrolysis compared with day 3. (C) α 1B Adrenoreceptor-expressing cells were transiently transfected with TG/pcDNA, and then PI hydrolysis in response to phenylephrine (50 µM), and the levels of tTG in the corresponding groups, were measured quantitatively at the time periods indicated after transfection. A slight increase in tTG levels (12 h) resulted in an increase in phenylephrine-stimulated PI hydrolysis, whereas higher levels of tTG expression (24 and 48 h) significantly attenuated PI hydrolysis in response to phenylephrine compared with 12 h. The inset in (C) shows a representative immunoblot of tTG levels. In all panels PI hydrolysis activity was expressed as percentage of control (CTL), and results were considered significantly different when P 0.05 (n l 3-5 independent experiments, each in triplicate). All immunoblots for detecting tTG expression were probed with the tTG monoclonal antibody 4C1 instead of TG100. (D) α 1B Adrenoreceptor-expressing cells were differentiated with 1 or 10 µM retinoic acid for 3 days or with 5 µM azacytidine for 6 days, and PI hydrolysis in response to the stimulation by carbachol (1 mM) was measured quantitatively. The data are expressed as meanspS.E.M. (n l 3). The data reveal that carbachol-stimulated PI hydrolysis was not affected by treating the cells with the drugs indicated.
stably transfected with the α "B adrenoreceptor were used to allow precise control of the amount of tTG present. In these experiments PI hydrolysis was measured in the presence of varying concentrations of exogenously added tTG. Because this is a cellfree system, addition of exogenous GTPγS, a stable analogue of GTP, is necessary to support receptor-coupled, G-proteinmediated, PI hydrolysis. At the lower concentrations of tTG (2.4 and 6.1 nM) phenylephrine-stimulated PI hydrolysis was not significantly increased compared with hydrolysis with no tTG added, but higher concentrations of tTG significantly inhibited PI hydrolysis ( Figure 6 ). As a control, 24 nM BSA (the highest concentration of tTG used) was added, and this treatment had no effect on the PI hydrolysis ( Figure 6 ).
G q/11 and tTG both contribute to α 1B adrenoreceptor signalling
To determine the relative contributions of tTG and G q/"" to signalling through the α "B adrenoreceptor, α "B adrenoreceptorexpressing cells were permeabilized and incubated with polyclonal antibodies to either the α-subunit of G q/"" or tTG (10 µg\ml) prior to measurements of PI hydrolysis. Control cells Bimodal effects of tissue transglutaminase on adrenoreceptor function
Figure 6 Exogenously added tTG modulates PI hydrolysis
Purified membranes prepared from α 1B adrenoreceptor cells were used to measure PI hydrolysis in the presence of increasing concentrations of tTG as described in the Experimental section. PI hydrolysis is expressed as c.p.m., and the data presented are the meanspS.E.M. from three separate experiments done in triplicate. Although tTG did not significantly increase phenylephrine (PE)-stimulated PI hydrolysis, higher concentrations of tTG (12.2 and 24.4 nM) significantly inhibited PI hydrolysis. As a control, 24 nM BSA was included in the reaction (the highest concentration of tTG used), and had no effect on the PI hydrolysis. *, P 0.05, significantly different from GTPγS and PE alone ; N, P 0.05, significantly different from GTPγS alone.
were incubated with an equivalent amount of non-immune rabbit IgG. Pre-incubation with the Gα q/"" antibody inhibited phenylephrine-stimulated PI hydrolysis by more than 85 % ; however, pre-incubation with the tTG antibody only inhibited phenylephrine-stimulated PI hydrolysis by $ 25 %. Pre-treatment with both antibodies completely inhibited phenylephrinestimulated PI hydrolysis. Non-immune rabbit IgG had no effect on PI hydrolysis (Figure 7 ). These data suggest that endogenous tTG facilitates phenylephrine-stimulated PI hydrolysis, but the contribution of tTG to α "B adrenoreceptor-stimulated PI hydrolysis is significantly less than G q/"" .
Inactivation of G q/11 activity by inhibition of palymitoylation and tyrosine phosphorylation
In order to assess further the relative contributions of G q/"" and tTG in mediating receptor-coupled PI hydrolysis, posttranslational modifications of G q/"" were targeted. tTG is neither palmitoylated [37] nor tyrosine phosphorylated (J. Zhang and J. Tucholski, unpublished work), whereas palmitoylation [38] and tyrosine phosphorylation [39] have been reported to be crucial modifications for regulating the optimal functioning of G q/"" . Therefore the difference in the extent of inhibition of carbacholand phenylephrine-stimulated PI hydrolysis in response to inhibition of palmitoylation or tyrosine phosphorylation was assessed to obtain an estimate of the relative contribution of tTG to signalling through the α "B adrenoreceptor. For these studies two drugs were used. Fluoropalmitic acid has been shown previously to inhibit the palymitolyation and function of the α-subunit of heterotrimeric G-proteins [40] . Gα q/"" is activated by tyrosine phosphorylation and genistein, a tyrosine kinase inhibitor, inhibits this response [39] . Therefore, in these studies cells were pretreated for 30 min with 300 µM 2-fluoropalmitic
Figure 7 Inhibition of phenylephrine (PE)-stimulated PI hydrolysis by antibodies to G q/11 and tTG in streptolysin-O-permeabilized cells
Addition of Gα q/11 antibody inhibited PI hydrolysis more than 85 % ; however, addition of the tTG antibody only inhibited phenylephrine-stimulated PI hydrolysis by $ 25 %. If both antibodies were added together, phenylephrine-stimulated PI hydrolysis was completely inhibited. As a control, an equivalent amount of non-immune rabbit IgG was added, and had no effect on PI hydrolysis. All antibodies were added at a final concentration of 10 µg/ml. The data presented are the meanspS.E.M. from three separate experiments done in triplicate ; *, P 0.05 values were significantly different when compared with cells treated with phenylephrine alone. 3 H]inositol, and then pretreated with no additions, 100 µM genistein for 10 min to inhibit tyrosine phosphorylation or 300 µM 2-fluoropalmitic acid for 30 min to inhibit palmitoylation prior to measurement of carbachol or phenylephrine-stimulated PI hydrolysis. Significantly less inhibition (P 0.0001) of phenylephrine-stimulated PI hydrolysis occurred in response to both 2-fluoropalmitic acid and genistein compared with carbachol-stimulated PI hydrolysis. Results are the means from five independent experiments performed in triplicate. acid to inhibit palymitoylation [40] or 10 min with 100 µM genistein to inhibit tyrosine phosphorylation [39] prior to measurement of carbachol-or phenylephrine-stimulated PI hydrolysis. The results of these experiments are summarized in Table 1 . As predicted from their inhibitory effects on the function of G q/"", both 2-fluoropalmitic acid and genistein substantially inhibited carbachol-stimulated PI hydrolysis. However, significantly less inhibition of phenylephrine-stimulated PI hydrolysis occurred with both 2-fluoropalmitic acid and genistein compared with carbachol-stimulated PI hydrolysis (P 0.0001, Table 1 ). The contribution of tTG to the phenylephrine-stimulated signalling can be estimated from the difference between the amount of inhibition observed for carbachol-and phenylephrine-stimulated PI hydrolysis, which was 15-16 %, similar to the estimation obtained by inhibiting PI hydrolysis with tTG antibodies. This indicates further that tTG contributes to α "B adrenoreceptor-stimulated PI hydrolysis, but that G q/"" plays the predominant role in mediating this process.
DISCUSSION
This study revealed two unique characteristics about the interaction of tTG with the α "B adrenoreceptor. First, tTG, as opposed to the heterotrimeric G-proteins, bimodally regulates α "B adrenoreceptor-mediated PI hydrolysis, with low levels of tTG being facilitory and high levels being inhibitory. The second characteristic identified that is unique to tTG is that the receptors contribute to the recruitment of tTG to the membrane, its probable site of activity when functioning as a G-protein.
Furthermore, agonist-induced activation of α "B adrenoreceptors enhanced the translocation of tTG to the membrane. These findings suggest that GPCRs play an active role in regulating the activity of tTG by orienting tTG to allow it to assume its role as a G-protein.
Up-regulation by tTG of α "B adrenoreceptor-stimulated PI hydrolysis extends previous reports that tTG can couple to the α "B and α "D adrenoreceptors [4, [11] [12] [13] or the oxytocin receptor in myometrium [14] to mediate activation of PLC. In agreement with those results, phenylephrine-stimulated PI hydrolysis was facilitated by modest increases in tTG induced by retinoic acid, azacytidine or by transient transfection with tTG, and was inhibited by the presence of a tTG antibody. However, this study also revealed that relatively high levels of tTG inhibited GPCRstimulated PI hydrolysis. Indeed, an earlier study provided preliminary evidence that tTG may bimodally regulate α "B adrenoreceptor-stimulated PI hydrolysis. Reconstitution studies using phospholipid vesicles indicated that calcium biphasically regulated α "B adrenoreceptor-tTG-coupled PI hydrolysis, and that longer times of incubation resulted in significantly less α "B adrenoreceptor-stimulated PI hydrolysis [41] . The findings presented in this present study provide additional evidence that tTG is a unique GTP-binding protein that regulates GPCR signalling in a manner that is distinct from the α-subunit of the heterotrimeric G-proteins [13, 42] . Indeed, tTG shows no homology with the α-subunits of the heterotrimeric G-proteins [2, 13, 26] , and the nucleotide-binding and hydrolytic characteristics of tTG are distinctly different from Gα q/"" . For example, the rate of hydrolysis of bound GTP is 0.8 min −" for Gα q/"" [43] , whereas it is approximately 10-fold lower (0.06 min −" ) for tTG [9] . Furthermore, tTG has a much lower affinity for GTP than G q/"" . tTG binds GTP with a K m of $ 130 µM, whereas G q/"" binds GTP with a K m of 0.3 µM [9, 42] . Additionally, heterotrimeric G-protein α-subunits do not show significant ATP binding [2, 44, 45] , whereas tTG has a higher affinity for ATP (K m $ 38 µM) than GTP, and the binding of ATP potently inhibits the GTPase activity of tTG (IC &! l 24 µM) [9] . Given that the concentration of ATP in the cell is estimated to be at least 1 mM [46] , it is likely that under physiological conditions the GTPase activity of free tTG is inhibited, and thus tTG would be predominantly in a constitutively GTP-bound state. These results suggest that, unlike heterotrimeric G-proteins, which are activated by receptor-induced binding of GTP, GTP-bound tTG is recruited to specific receptors, and ligand binding may enhance this translocation of tTG to the membrane. Further, the results from this study indicate that the contribution of tTG to α "B adrenoreceptor-stimulated PI hydrolysis is significantly less than that of G q/"" , indicating that tTG is likely to have a more modulatory role in regulating signalling through GPCRs. Presently, the mechanism by which tTG can both facilitate and diminish α "B adrenoreceptor-stimulated PI hydrolysis depending on the cellular level of tTG is not clear. However, given the results, one plausible hypothesis is that the α "B adrenoreceptortTG-PLCδ signalling module is less efficient at stimulating PI hydrolysis than the α "B adrenoreceptor-G q/"" -PLCβ signalling complex. For example, this was evident when Gα q/"" was inactivated by introduction of a G q/"" α-subunit antibody, which greatly reduced α "B adrenoreceptor-stimulated PI hydrolysis, whereas exposure to a tTG antibody caused a significantly smaller reduction in receptor-activated PI hydrolysis. Hence, at lower concentrations tTG may contribute to α "B adrenoreceptorstimulated PI hydrolysis, albeit with lower efficiency than the heterotrimeric G-protein, but at higher concentrations more tTG may be bound to receptor and thus decrease the efficiency of α "B adrenoreceptor-G q/"" coupling, resulting in less PI hydrolysis. Thus these results indicate that tTG plays a unique modulatory role in regulating α "B adrenoreceptor-activated PI hydrolysis. tTG displays the unique characteristic of being selectively recruited to the plasma membrane by the α "B adrenoreceptor and this recruitment is enhanced by activation of the receptor with agonist. Previous studies have demonstrated that a complex of agonist, α " adrenoreceptor and tTG can be isolated from rat liver membranes [4, 47] . However, to our knowledge, this study is the first to demonstrate that recruitment of tTG from the cytoplasm to the membrane is dependent upon the α "B adrenoreceptor, and that this translocation is enhanced by agonist stimulation. In addition, PLCδ is also recruited to the membrane by the presence of the receptor, presumably through its association with tTG [12] . In contrast, heterotrimeric G-proteins have not been shown to be recruited by receptors to the plasma membrane, although GPCRs that share a common α-subunit can interact by regulating the redistribution of their G-proteins [48] . Additionally, Gα q/"" activates PLCβ, not PLCδ, and does not selectively recruit the enzyme to the membrane [18] . Further, tTG apparently does not require auxiliary proteins to interact with the receptor [13, 20] . In contrast, the α-subunit without GTP bound interacts with the GPCR as part of the αβγ heterotrimeric G-protein complex, and there is good evidence for receptorcontact surfaces on all three subunits [49, 50] . It is also of interest that tTG shows significant selectivity in its interactions with GPCRs, and only modulates the activity of the α "B and α "D adrenoreceptors and the oxytocin receptor [11, 14] . In contrast, G q/"" shows a high degree of promiscuity, effectively coupling to numerous GPCRs, including all the α " adrenoreceptor subtypes, muscarinic receptors, the bombesin receptor and many others [16, 51] . Given the lack of sequence homology between G q/"" and tTG [26, 52] , as well as the findings cited above and the data from this study, it is likely that G q/"" and tTG interact differentially with the α "B adrenoreceptor. Although the third intracellular loop of the α "B adrenoreceptor contains interaction sites for both G q/"" and tTG [11] , these proteins are likely to bind differentially to specific sites in this region on the receptor, and to be activated by different mechanisms.
In conclusion, these studies demonstrate that tTG is a novel signal transducing G-protein that bimodally regulates agoniststimulated PI hydrolysis through a limited number of GPCRs. This is the first identification of a protein having the capacity to both facilitate and to attenuate GPCR-stimulated PI hydrolysis in a concentration-dependent manner. This type of regulation may allow the cell to ' fine tune ' its response to specific signals. Indeed the recent discovery of the RGS (regulator of G-protein signalling) proteins, which also regulate GPCR signalling [53] , further underscores the complexity of these signalling processes. Continuing investigations into the role of tTG in modulating GPCR signalling is clearly required to fully elucidate the function of this protein in its capacity as a novel G-protein.
